chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt sick throughout the next two days. Site is swollen with a rash  and fevered. Went away after a few days but the rash., swelling and itching is back after the seventh day of getting the shot
Encephalitis; Meningitis; This spontaneous case was reported by a consumer and describes the occurrence of ENCEPHALITIS (Encephalitis) and MENINGITIS (Meningitis) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) for an unknown indication.    No Medical History information was reported.   In April 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient received first dose of VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) (unknown route) 1 dosage form. On 09-Aug-2021, received second dose of VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ENCEPHALITIS (Encephalitis) (seriousness criterion medically significant) and MENINGITIS (Meningitis) (seriousness criterion medically significant). At the time of the report, ENCEPHALITIS (Encephalitis) and MENINGITIS (Meningitis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.   It was reported that consumer was to confused and could not answer more questions.  Company Comment : This case concerns a patient with gender and age unknown with no relevant history reported in this case, who experienced the serious unexpected events of Encephalitis and Meningitis. The events occurred on an unknow date, there is no information reported related the latency with the dose of the Moderna COVID-19 Vaccine. The rechallenge is unknown for the events since no information about the dose sequence is provided. Concomitant medication reported as SHINGRIX (VARICELLA ZOSTER VACCINE RGE (CHO)) reminds as a confounder/co-suspects for the events. The events were considered related to the study drug as per the reporter's assessment with the presence of confounding mentioned factors. The benefit-risk relationship of drug x in not affected by this report.; Sender's Comments: This case concerns a patient with gender and age unknown with no relevant history reported in this case, who experienced the serious unexpected events of Encephalitis and Meningitis. The events occurred on an unknow date, there is no information reported related the latency with the dose of the Moderna COVID-19 Vaccine. The rechallenge is unknown for the events since no information about the dose sequence is provided. Concomitant medication reported as SHINGRIX (VARICELLA ZOSTER VACCINE RGE (CHO)) reminds as a confounder/co-suspects for the events. The events were considered related to the study drug as per the reporter's assessment with the presence of confounding mentioned factors. The benefit-risk relationship of drug x in not affected by this report.
Had Pain at injection site for about a month then developed pain in my lower arm,then started having pain in my elbow and finger joints  Still have significant pain and tenderness especially in the joints of my left arm and fingers  . Need to take motrin everyday.
pt recv vax 13AUG97 & 15SEP97 pt devel a temp of 103;
gave 0.25mL by accident instead of the full dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (gave 0.25mL by accident instead of the full dose) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 28-Mar-2022, the patient experienced ACCIDENTAL UNDERDOSE (gave 0.25mL by accident instead of the full dose). At the time of the report, ACCIDENTAL UNDERDOSE (gave 0.25mL by accident instead of the full dose) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
Hives developed before other vaccines administered after Rotateq before other vaccines given. This is in follow-up to reports previously submitted on 1/16/2007. Information has been received from a physician and a registered nurse concerning a 9-week old male who on 29-Sep-2006, immediately after the administration of ROTATEQ, the patient developed a mild case of hives before other vaccines could be given. Unspecified medical attention was sought. There was no swelling and no respiratory distress. The patient was monitored and after about 10 minutes, the hives subsided. The patient did not need long-term care and there were no other reactions noted. It was also noted that the series of ROTATEQ was discontinued after the first dose. Additional information is not expected.
Rt upper arm red, warm to touch, swollen (erythema > 10cm)
This spontaneous report was received from a licensed vocational nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of ZOSTAVAX (lot # L013546 with expiration date 17-JUL-2016; dose and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Patient received Moderna vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2022 at 11:56 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 07-Feb-2022 at 11:56 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   No treatment medication was reported by reporter. Patient's race was  of any race.
Her arm hurts so badly that she can't raise it more than a 90 degree angle from her side; Her arm hurts so badly that she can't raise it more than a 90 degree angle from her side; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 15 year-old female patient received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious) all with onset May2021, outcome "unknown" and all described as "Her arm hurts so badly that she can't raise it more than a 90 degree angle from her side".  Additional Information: My daughter, (withheld), age 15, got her first COVID dose yesterday after school. Today her arm hurts so badly that she can't raise it more than a 90 degree angle from her side. She was able to attend school today, it seems to be tolerable if she doesn't move it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I was due October 1st. I just found out I was pregnant before my first Vaccine. After my vaccine I was extremely sick. I was sick about a month after vaccine and went to the ER twice. and I miscarried on March 4.
Woke up day after shot feeling general malaise, body aches, very sore at injection sight.  Took Naproxum sodium, slept it off in afternoon and feel better.
103.1 fever, chills, severe.body aches, weakness, severe headache.
Painful vesicular rash in a dermatomal distribution (looks like shingles). Patient had been symptomatic for one week, no treatment given.
Migraine; Body ache; Cough; Threw Up; On 3rd daytemperature 99 F; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), PAIN (Body ache), COUGH (Cough), VOMITING (Threw Up) and PYREXIA (On 3rd daytemperature 99 F) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine), COUGH (Cough), VOMITING (Threw Up) and PYREXIA (On 3rd daytemperature 99 F). an unknown date, the patient experienced PAIN (Body ache). At the time of the report, MIGRAINE (Migraine), VOMITING (Threw Up) and PYREXIA (On 3rd daytemperature 99 F) outcome was unknown and PAIN (Body ache) and COUGH (Cough) had resolved.       Date: Unk, Body temperature: 99F  No information regarding treatment medications was provided by the reporter.   This case was linked to MOD-2021-019704 (Patient Link).
pt recv vax & exp arthralgia;tx advil, pred;pt returned to see pharmacist p/pred was stopped;
never received the second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 57-year-old female patient who received HAB (Twinrix adult) for prophylaxis.   Previously administered products included Twinrix adult (received 1st dose in December 2022 with batch number 2KE55 and expiry date 22nd September 2022).   On an unknown date, the patient did not receive the 2nd dose of Twinrix adult. On an unknown date, an unknown time after receiving Twinrix adult, the patient experienced incomplete course of vaccination (Verbatim: never received the second dose). The outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 30-JUN-2023 The pharmacist called to inquired how to proceed with the Twinrix series. Any guidance on remainder doses. The reporter did not consent to follow-up. Till the time of reporting, the patient did not receive the 2nd dose of Twinrix adult, which led to incomplete course of vaccination.
Reports that she had significant swelling of her arm after receiving the PNEUMOVAX 23 vaccine during her 5/30/18 office visit, and as the swelling went down, she started having the dizziness that took her to the ED for evaluation on 6/6/18. They stated that her reaction should be reported.
Headache, Diarrhea, malaise H/A arm pain loose stools Narrative:
Next morning woke up with pain and discomfort on armpit as if pulled a muscle. It got worse over time. Then burning sensation started. Performed a tactile test and noticed nodules where the size of golf balls and tender to touch. No adverse event on immunization site. Went to doctor and lymph nodes size of apple and eventually increased to size of grapefruit. It is painful and tender to touch. Took ibuprofen and using cold/heat packs to see if it gets better. No improvement so far. Has taken flu shot yearly with no problems until this year.
Started with feeling like heart was racing, tightness/pressure in the forehead and through the sinuses. lightheadedness.
Itching, hives and swelling all over body...started Mar 27th and still having itching and hives
Came in on 7/2/12 for wellness check up and received her 12 month immunization- varicella, MMR, hep a and PCV 13. Per mother broke out in rash that night and fever - low grade (mom did not check temp).
10 days after vaccines given, mother brings patient in for a generalized body rash. Dx: urticaria.
the left side of her lip was swollen and became numb; the left side of her lip was swollen and became numb; small allergic reaction; This is a spontaneous report from a contactable consumer or other non hcp reporting for herself (patient).  A female patient of an unspecified age received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL1284; Expiration Date: 30Apr2021) via an unspecified route of administration, administered in Arm Left on 21Jan2021 at 11:00 age at vaccination: 30 years old as dose 1, single for covid-19 immunization at the Clinic. The patient medical history and concomitant medications were not reported. The patient was not pregnant at the time of vaccination. Patient Historical vaccine included Flu shot in Jan2021 for immunization. The patient experienced the left side of her lip was swollen and became numb on 21Jan2021 and small allergic reaction on 21Jan2021. Patient stated patient experienced on 21Jan2021 that when she got the first dose, she had a small allergic reaction, the left side of her lip was swollen, and became numb. Patient further stated when she went home, she put ice on it, and it was gone the next day. The patient underwent lab tests and procedures which included pregnancy test negative and bloodwork pregnancy test negative on unknown date. The outcome of events was outcome of recovered on 22Jan2021.  No follow-up attempts are needed. No further information is expected.
Patient began feeling lightheaded and faint while sitting down approximately five minutes after the vaccination administration.  Within 2 minutes of this the patient began having a seizure that lasted for approximately 30 seconds.  Patient slid to the floor and become unresponsive.  An Epi-pen was administered and shortly after patient stabilized and regained consciousness.  Within 2 minutes he was able to answer questions and was oriented to place and time.  Within 10 minutes the paramedics were on scene and patient was stable and talking to them.  They recorded a blood pressure of 130/90 at this time.  They took him to the local hospital from here.
Pt states while getting dressed this morning he noticed redness surround the site where he received a pneumonia shot x 9 days ago, he was advised by another MD he saw today for non related issue to come to office and report. Pt denies any symptoms or pain - erythema 3in x 1 3/4" (L) deltoid.
Patient seen in the ED after being sent from Drs office and found to have retinal hemorrhages; thought to be combination of hypertensive and diabetic retinopathy as contributing factors; however, patient feels very strongly that her vision became worse after her first dose of Moderna vaccine (the next day) and then significantly worse after the 2nd dose (again the next day) prompting her to come into ED for evaluation and then following up at Drs office visit and being sent to the ED.
This spontaneous report as received from a nurse practitioner refers to a 17 year old female patient with one medical history and drug allergies. On 22-AUG-2014 the patient was administered the first dose of GARDASIL (0.5 ml, intramuscular, lot not report) series on 22-AUG-2014. Patient was also administered MENACTRA on 22-AUG-2014 in the other arm. Nurse practitioner received a phone call from the patient's mother on an unspecified date. Patient's mother stated that her daughter, was experiencing a headache which began on 23-AUG-2014. The headache was described as pretty constant. Patient was described by her mother as able to function however she was not herself. Treatment recommended by nurse practitioner was ALEVE, eating and drinking liquids. Patient was scheduled for an appointment at the office of nurse practitioner on 28-AUG-2014. None lab diagnostics studies performed. The outcome of adverse events was not recovered. Additional information has been requested.
This case was reported by a physician and described the occurrence of hepatitis B surface antigen positive in a 68-year-old male subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Previous vaccination included 1st dose of ENGERIX B given on an unspecified date. On 1 August 2011 the subject received 2nd dose of ENGERIX B (details unknown). On 3 August 2011, 2 days after vaccination with ENGERIX B, the subject experienced hepatitis B surface antigen positive. He had a positive titer for surface antigen hepatitis B. The subject was placed in isolation for approximately 2 days. Dates of the isolation were not reported. The physician considered the event was clinically significant (or requiring intervention). At the time of reporting the event was resolved. The physician considered the event was probably related to vaccination with ENGERIX B.
Within a month (roughly around the time of the second dose), I started having extremely irregular heart rate, increased heart rate even while resting, and a lot of fatigue. Increased dietary issues have also come up and nothing has subsided since getting the vaccine, even though I?ve tried many things to get back to normal.
Information has been received from a healthcare worker (medical assistant) referring to an unspecified number of patients of unknown age and gender. On 13-FEB-2015 the patients were vaccinated with an unspecified number of improperly stored doses of ZOSTAVAX (lot # was reported as K010336, expiration date 22-JUL-2016; another lot# was reported as K019388, expiration date 20-JAN-2016; dose, route were not reported). No adverse effect was reported. This is one of several cases reported by the same reporter. Additional information has been requested.
Extreme itchiness accompanied with dermatographia on most of my body.  Additionally light tightness in asophagus
06/04/02, vaccine given at 10am in well-child clinic. Tylenol and cold compresses used alter that evening. 06/05/02 T. 103, swelling left deltoid elevated temp cont. all day. Parent contacted ER-no visit. 0606/02 parent contacted health dept-encouraged to got o ER. Inst. to apply H2O2 left deltoid with swelling reddish purple hot to touch per parent.
pt recv vax 18JUN98 & 22JUN98 pt devel fever & aching;dx viremia reaction;
Acute chest pain two days after Pfizer SARS-COV-2 vaccine. Troponin 11.86 at admission on 8/20, peaked at 18.52, normalized 9/2. Echocardiogram normal, EKGs normal.
Extreme soreness in arm, swelling at injection site, increased muscle and joint pain, mild nausea, feeling to warm (though thermometer indicated normal body temperature) and fatigue. Worst time was second evening after injection. Two days after injection, symptoms improving slightly.
woke up sick to her stomach and threw up three to four times/nauseated; woke up sick to her stomach and threw up three to four times/nauseated; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 22Mar2021 15:00 (Lot number: EN9809) at the age of 60 years as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "Type 2 Diabetic", start date: 2016 (ongoing), notes: Diagnosed about 5 years ago. There were no concomitant medications. The following information was reported: VOMITING (non-serious), NAUSEA (non-serious) all with onset 23Mar2021, outcome "recovered" (23Mar2021) and all described as "woke up sick to her stomach and threw up three to four times/nauseated".  Additional information: The patient had no relevant family medical history. The patient had no history of previous immunization with Pfizer vaccine considered as suspect. The patient had no additional vaccines administered on same date of the Pfizer suspect. The vaccine was administered in a hospital. The events onset time was 03:30-04:00. The patient had no prior vaccinations (within 4 weeks). The events did not require a visit to emergency room or physician office.  No follow-up attempts are possible. No further information is expected.
Redness; Yellow blistering; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s):   A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ERYTHEMA (non-serious), outcome "unknown", described as "Redness"; BLISTER (non-serious), outcome "unknown", described as "Yellow blistering".  Additional information: Reporter following information relating to vaccine COVID-19 Pfizer BioNTech received by one of our associates during the normal course of business.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Sever body chills, sweats, all over body aches, no appetite, flu like symptoms, severe migraine, fever,
Client received yellow fever vaccine #2 and MMR #2 on 6/16/08. Client had previously received a yellow fever vaccine approximately 10 years ago with no problems. MMR #1 was given 5/17/08 with no problems for patient. Client reported the following symptoms which started at 1600 on 6/17/08, no dizziness, HA, SOB/Chest tightness, H/V which started at 1700 to 1730, and non-prominent rash on chest only which started on 6/18/08 none in the morning. Client called to report the symptoms at 0900. Instructed client to call PMD now that he must be seen by a provider today for evaluation. Per client doctor, she believes symptoms were caused by vaccine, although this cannot be certain as client cancelled stress test appt.
lightheadedness; feeling weak; This is a spontaneous report from a non-contactable other healthcare professional. A 43-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration on an unknown date (at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date, during 15 minutes waiting period after the vaccination, the patient experienced light-headedness and felt weak. Therapeutic measures taken as a result of the reported events included water and snacks. It was reported that patient responded good to follow up treatment and the patient was stable to go to home and was asked to follow up with primary care physician (PCP). The differential diagnosis was reported as vaccine related anxiety (included misc mental health, as reported). The clinical outcome of events light-headedness and feeling weak was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.